<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Candela Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/candela-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(ELOS) Syneron Medical to Acquire Primaeva Medical</title>
		<link>http://www.stockbloghub.com/2009/10/17/elos-syneron-medical-to-acquire-primaeva-medical/18059</link>
		<comments>http://www.stockbloghub.com/2009/10/17/elos-syneron-medical-to-acquire-primaeva-medical/18059#comments</comments>
		<pubDate>Sat, 17 Oct 2009 21:23:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Candela Corporation]]></category>
		<category><![CDATA[CLZR]]></category>
		<category><![CDATA[ELOS]]></category>
		<category><![CDATA[Regions Financial Corporation]]></category>
		<category><![CDATA[RF]]></category>
		<category><![CDATA[Syneron Medical Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18059</guid>
		<description><![CDATA[Syneron Medical Ltd. (ELOS) is set to acquire Primaeva Medical, Inc., an aesthetic technology firm based in Pleasanton, CA. The acquisition is expected to close before the end of 2009. Per the agreement, Syneron will acquire Primaeva for $7 million in cash and up to $23 million of additional payment based on the achievement of certain milestones. The Primaeva acquisition helps Syneron gain access to a new technology for the treatment of wrinkles. The Primaeva product uses the bipolar fractional radiofrequency (RF) energy for the treatment of skin wrinkles and laxity in a selective and predictable manner. Its unique energy delivery mechanism resulted in skin tightening with minimal downtime. An important consideration in skin treatment is the excessive heating of skin. The Primaeva product eliminates this as the treatment temperature ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/17/elos-syneron-medical-to-acquire-primaeva-medical/18059/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(SLTM) Solta Medical&#8217;s Laser Device Approved by The FDA</title>
		<link>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788</link>
		<comments>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788#comments</comments>
		<pubDate>Thu, 15 Oct 2009 21:48:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[AGN]]></category>
		<category><![CDATA[Allergan Inc.]]></category>
		<category><![CDATA[Candela Corporation]]></category>
		<category><![CDATA[CLZR]]></category>
		<category><![CDATA[SLTM]]></category>
		<category><![CDATA[Solta Medical Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17788</guid>
		<description><![CDATA[After the closing bell on Wednesday, Solta Medical Inc. (SLTM) announced that the U.S. Food and Drug Administration (FDA) approved its device to clear pigmentation and other superficial skin conditions. The device, called the Fraxel re:store Dual Laser System, can be used both on the face and large body areas to clear pigmentation through a single treatment. Solta has already received approval for the device with 1550 nanometer (nm) wavelength for skin resurfacing and treatment of pigmented lesions and certain other dermatological conditions. The present FDA 510(k) clearance is for the Fraxel 1927 nm laser for dermatological procedures requiring the coagulation of soft tissue. Prior to its approval, laser skin resurfacing procedures were largely limited to the face. The approval of the new 1927 nm wavelength increases the areas of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/15/sltm-solta-medicals-laser-device-approved-by-the-fda/17788/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ELOS) Syneron Medical Ltd to Purchase Candela</title>
		<link>http://www.stockbloghub.com/2009/09/10/elos-syneron-medical-ltd-to-purchase-candela/14899</link>
		<comments>http://www.stockbloghub.com/2009/09/10/elos-syneron-medical-ltd-to-purchase-candela/14899#comments</comments>
		<pubDate>Fri, 11 Sep 2009 01:58:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Candela Corporation]]></category>
		<category><![CDATA[CLZR]]></category>
		<category><![CDATA[ELOS]]></category>
		<category><![CDATA[Syneron Medical Ltd]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=14899</guid>
		<description><![CDATA[Yesterday, Syneron Medical Ltd (ELOS) announced that it would buy Candela Corp. (CLZR) in a $65 million all-stock transaction. The merger is expected to be completed by year-end. It was agreed that Candela stockholders would receive 0.2911 ordinary shares of Syneron for each share of Candela. 6.7 million shares will be issued by Syneron for the acquisition at about $2.84 per share. This is 51% above Candela’s Tuesday closing price of $1.88. Therefore, the merger is of financial benefit to Candela stockholders. The merger will result in two medical laser technology providers for aesthetic treatments such as hair removal, wrinkle reduction, acne treatment etc. coming under one roof. The significant cost and product synergies resulting from the deal will increase the international exposure of the merged entity with approximately 62% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/09/10/elos-syneron-medical-ltd-to-purchase-candela/14899/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

